RT Journal Article
SR Electronic
T1 Analysis of COVID-19 case numbers: adjustment for diagnostic misclassification on the example of German case reporting data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.29.20203877
DO 10.1101/2020.09.29.20203877
A1 Günther, Felix
A1 Berger, Ursula
A1 Höhle, Michael
A1 Bender, Andreas
A1 Wildner, Manfred
A1 Heid, Iris M.
A1 Küchenhoff, Helmut
YR 2021
UL http://medrxiv.org/content/early/2021/03/10/2020.09.29.20203877.abstract
AB Background Reported COVID-19 case numbers are key to monitoring pandemic spread and decision-making on policy measures but require careful interpretation as they depend substantially on testing strategy. A high and targeted testing activity is essential for a successful Test-Trace-Isolate strategy. However, it also leads to increased numbers of false-positives and can foster a debate on the actual pandemic state, which can slow down action and acceptance of containment measures.Aim We evaluate the impact of misclassification in COVID-19 diagnostics on reported case numbers and estimated numbers of disease onsets (epidemic curve).Methods We developed a statistical adjustment of reported case numbers for erroneous diagnostic results that facilitates a misclassification-adjusted real-time estimation of the epidemic curve based on nowcasting. Under realistic misclassification scenarios, we provide adjusted case numbers for Germany and illustrate misclassification-adjusted nowcasting for Bavarian data.Results We quantify the impact of diagnostic misclassification on time-series of reported case numbers, highlighting the relevance of a specificity smaller than one when test activity changes over time. Adjusting for misclassification, we find that the increase of cases starting in July might have been smaller than indicated by raw case counts, but cannot be fully explained by increasing numbers of false-positives due to increased testing. The effect of misclassification becomes negligible when true incidence is high.Conclusions Adjusting case numbers for misclassification can improve this important measure on short-term dynamics of the pandemic and should be considered in data-based surveillance. Further limitations of case reporting data exist and have to be considered.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Bavarian State Medical Association (Bayerische Landesaerztekammer - BLAEK) has approved the statistical evaluation of the anonymised person-specific reporting data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode for reproducing our analysis and adapting it to other application scenarios is available at Github. There, we also provide an artificial data set on the person-specific case reporting data from Bavaria. https://github.com/FelixGuenther/mc_covid_cases_public